All articles by Staff Writer
Staff Writer
An over-the-counter RT-PCR system to detect infectious diseases
The Covid-19 pandemic made clear the global need for rapid, accurate and accessible at-home testing. CO-Diagnostics (Co-Dx) presents its PCR platform, Co-Dx PCR Home, to allow for easy and non-invasive diagnosis at home or in clinics.
Rapid and reliable testing for viral diseases
Accurate, robust and easy-to-use molecular testing of viral meningitis/encephalitis is essential for optimal patient management. To address this challenge, Uniogen has launched a new automated PCR test.
Intelligent automation solutions for IFA
New automation systems for indirect immunofluorescence from EUROIMMUN aid workflow optimisation and analysis standardisation. The UNIQO 160 is designed for complete walkaway automation of IFA, while the EUROLabPolaris software enables digital connection of laboratory sites for centralised evaluation of IFA results. Both products are now CE-marked.
Meridian Bioscience Continues Expansion of H. pylori Diagnostic Testing Solutions with FDA Clearance of Premier HpSA Flex
Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) has cleared Premier® HpSA® FLEX™ for the diagnosis of H. pylori in both preserved and unpreserved stools. Premier HpSA Flex joins the extensive Meridian H. pylori portfolio of products that includes BreathID® (urea breath test for H. pylori), Curian® HpSA (fluorescent immuno analyzer antigen test), and ImmunoCard® Stat! HpSA (rapid colorimetric antigen test).
Launch of the FlexStar® CT & NG PCR Detection Mix 1.5 (RUO)
altona has recently launched the FlexStar® CT & NG PCR Detection Mix 1.5 (RUO), our first product of the STI (sexually transmitted infection) panel.
Stemline therapeutics, a subsidiary of menarini group, receives u.s. Fda approval for orserdu™ (elacestrant) as the first and only treatment specifically indicated for patients with esr1 mutations in er+, her2- advanced or metastatic breast cancer
ESR1 mutations are present in up to 40% of ER+, HER2- advanced or metastatic breast cancers.
ESR1 mutations are a known driver of resistance to standard endocrine therapy, and so far, have been difficult to treat.
ORSERDU is the first endocrine innovation in more than 20 years, specifically addressing ESR1 mutations, a major unmet need.
Launch of new cardiovascular disease guidelines
The Albanese Government has today launched the first major update to the cardiovascular disease prevention guidelines in over a decade, in a move that the Heart Foundation estimates could impact the care of 8 million Australians.
Siemens Healthineers launches Atellica CI Analyzer, compact testing system to tackle lab challenges
Clinical labs face critical operational challenges that impede productivity—more patient samples to test, staffing shortages, and more documentation requirements.
The Atellica CI Analyzer for immunoassay and clinical chemistry testing aims to address labor shortage pain points and drive revenue growth, fostering agility beyond standardization and clinical equivalence.
Workflow advancements help labs achieve more predictable turnaround times, alleviate reporting burdens, and refocus staff attention on critical lab operations.
Bio-Rad enables laboratory excellence in immunohematology with launch of Ih-500 next fully automated system for Id-Cards
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards.
Thermo Fisher Scientific Introduces New Reproductive Health Assays to Accelerate Fertility Research
Combined with the Ion Torrent Genexus Integrated Sequencer, new assays deliver valuable genomic insights in the field of aneuploidy analysis